GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $400,000 | -12.1% | 9,191 | -12.0% | 0.16% | +6.8% |
Q1 2022 | $455,000 | -1.1% | 10,441 | 0.0% | 0.15% | +6.5% |
Q4 2021 | $460,000 | +18.9% | 10,441 | +3.2% | 0.14% | +13.1% |
Q3 2021 | $387,000 | -4.7% | 10,116 | 0.0% | 0.12% | -1.6% |
Q2 2021 | $406,000 | -0.2% | 10,116 | -11.4% | 0.12% | -14.5% |
Q1 2021 | $407,000 | -6.0% | 11,416 | -3.0% | 0.14% | -9.9% |
Q4 2020 | $433,000 | -2.3% | 11,766 | 0.0% | 0.16% | -16.1% |
Q3 2020 | $443,000 | -7.7% | 11,766 | 0.0% | 0.19% | -13.5% |
Q2 2020 | $480,000 | +7.6% | 11,766 | 0.0% | 0.22% | -11.2% |
Q1 2020 | $446,000 | -19.3% | 11,766 | 0.0% | 0.25% | +3.3% |
Q4 2019 | $553,000 | +9.5% | 11,766 | -0.5% | 0.24% | +0.4% |
Q3 2019 | $505,000 | +12.5% | 11,829 | +5.5% | 0.24% | +9.5% |
Q2 2019 | $449,000 | -5.7% | 11,216 | -1.5% | 0.22% | -10.2% |
Q1 2019 | $476,000 | +9.4% | 11,391 | 0.0% | 0.24% | -0.8% |
Q4 2018 | $435,000 | -3.3% | 11,391 | +1.8% | 0.25% | +6.5% |
Q3 2018 | $450,000 | +77.9% | 11,191 | +78.6% | 0.23% | +71.9% |
Q2 2018 | $253,000 | – | 6,266 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |